Paper40396273
Homoharringtonine exerts anti-silicosis potential by inhibiting the CCR1 and PI3K/AKT signaling pathways in lung fibroblasts.
Jia X and 7 others. J Biomed Res, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Homoharringtonine exerts anti-silicosis potential by inhibiting the CCR1 and PI3K/AKT signaling pathways in lung fibroblasts. Papers, record 40396273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40396273
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Homoharringtonine exerts anti-silicosis potential by inhibiting the CCR1 and PI3K/AKT signaling pathways in lung fibroblasts.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16197470 | Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3. | Allergy | 2005 | https://conductscience.org/library/papers/16197470 | PubMed |
| 2 | 37705751 | Apelin Prevents and Alleviates Crystalline Silica-induced Pulmonary Fibrosis via Inhibiting Transforming Growth Factor Beta 1-triggered Fibroblast Activation. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37705751 | PubMed |
| 3 | 34186034 | Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation. | Chest | 2021 | https://conductscience.org/library/papers/34186034 | PubMed |
| 4 | 38704602 | Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38704602 | PubMed |
| 5 | 35739508 | Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility. | Respir Res | 2022 | https://conductscience.org/library/papers/35739508 | PubMed |
| 6 | 34681590 | TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681590 | PubMed |
| 7 | 38316746 | Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM). | Blood Cancer J | 2024 | https://conductscience.org/library/papers/38316746 | PubMed |
| 8 | 37406748 | Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/37406748 | PubMed |
| 9 | 33407698 | Homoharringtonine inhibits fibroblasts proliferation, extracellular matrix production and reduces surgery-induced knee arthrofibrosis via PI3K/AKT/mTOR pathway-mediated apoptosis. | J Orthop Surg Res | 2021 | https://conductscience.org/library/papers/33407698 | PubMed |
| 10 | 33500731 | Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2. | Theranostics | 2021 | https://conductscience.org/library/papers/33500731 | PubMed |
| 11 | 20870892 | The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis. | Am J Respir Cell Mol Biol | 2011 | https://conductscience.org/library/papers/20870892 | PubMed |
| 12 | 36280590 | Clinical usefulness of serum angiotensin converting enzyme in silicosis. | Pulmonology | 2024 | https://conductscience.org/library/papers/36280590 | PubMed |
| 13 | 35191375 | A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. | Elife | 2022 | https://conductscience.org/library/papers/35191375 | PubMed |
| 14 | 36123435 | Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel. | Sci Rep | 2022 | https://conductscience.org/library/papers/36123435 | PubMed |
| 15 | 33466366 | Macrophage Autophagy and Silicosis: Current Perspective and Latest Insights. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33466366 | PubMed |
| 16 | 30953928 | Homoharringtonine Combined with the Heat Shock Protein 90 Inhibitor IPI504 in the Treatment of FLT3-ITD Acute Myeloid Leukemia. | Transl Oncol | 2019 | https://conductscience.org/library/papers/30953928 | PubMed |
| 17 | 36577208 | Yangqing Chenfei formula attenuates silica-induced pulmonary fibrosis by suppressing activation of fibroblast via regulating PI3K/AKT, JAK/STAT, and Wnt signaling pathway. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36577208 | PubMed |
| 18 | 36076611 | Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36076611 | PubMed |
| 19 | 31410197 | Targeting Mechanics-Induced Fibroblast Activation through CD44-RhoA-YAP Pathway Ameliorates Crystalline Silica-Induced Silicosis. | Theranostics | 2019 | https://conductscience.org/library/papers/31410197 | PubMed |
| 20 | 35551173 | Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35551173 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41893486 | The Toxic Effects of Hydrated Cement, Autoclaved Aerated Concrete, and Demolition Dusts on the Respiratory System in Rats. | Toxics | 2026 | https://conductscience.org/library/papers/41893486 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CCR1 | 1230 | PubTator's text mining | https://conductscience.org/library/genes/1230 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40396273
GET https://conductscience.org/api/papers/v1/40396273/references?page=2